Algert Global’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-19,580
Closed -$824K 1344
2025
Q4
$824K Buy
+19,580
New +$789K 0.01% 880
2025
Q1
Sell
-261,819
Closed -$10.4M 1334
2024
Q4
$10.4M Buy
261,819
+60,122
+30% +$2.28M 0.24% 100
2024
Q3
$6.87M Buy
201,697
+162,236
+411% +$4.56M 0.18% 155
2024
Q2
$855K Sell
39,461
-11,241
-22% -$236K 0.03% 726
2024
Q1
$1.12M Sell
50,702
-48,383
-49% -$1.18M 0.04% 588
2023
Q4
$2.73M Buy
99,085
+27,740
+39% +$670K 0.11% 314
2023
Q3
$1.59M Buy
71,345
+19,424
+37% +$500K 0.07% 444
2023
Q2
$1.32M Sell
51,921
-32,188
-38% -$780K 0.06% 555
2023
Q1
$1.88M Buy
84,109
+68,964
+455% +$1.67M 0.09% 377
2022
Q4
$359K Hold
15,145
0.02% 893
2022
Q3
$251K Sell
15,145
-1,275
-8% -$28.7K 0.02% 991
2022
Q2
$327K Buy
+16,420
New +$332K 0.02% 891
2021
Q4
Sell
-6,817
Closed -$317K 1126
2021
Q3
$317K Buy
+6,817
New +$297K 0.04% 741
2020
Q1
Sell
-9,270
Closed -$259K 523
2019
Q4
$259K Buy
+9,270
New +$240K 0.08% 280
2019
Q3
Sell
-47,180
Closed -$1.34M 440
2019
Q2
$1.34M Sell
47,180
-10,394
-18% -$260K 0.5% 69
2019
Q1
$1.44M Sell
57,574
-75,671
-57% -$1.45M 0.82% 23
2018
Q4
$1.68M Sell
133,245
-78,192
-37% -$925K 0.47% 66
2018
Q3
$2.02M Buy
211,437
+89,987
+74% +$992K 0.44% 79
2018
Q2
$1.13M Sell
121,450
-14,125
-10% -$99.3K 0.24% 166
2018
Q1
$754K Sell
135,575
-68,533
-34% -$424K 0.15% 218
2017
Q4
$1.33M Buy
204,108
+93,199
+84% +$693K 0.31% 136
2017
Q3
$973K Buy
110,909
+44,910
+68% +$365K 0.22% 175
2017
Q2
$550K Buy
+65,999
New +$538K 0.15% 211

Other funds holding VCYT

Algert Global's VCYT Position: Q1 2026 in Review

Algert Global sold out of Veracyte (VCYT) in Q1 2026, closing a stake of 19,580 shares — an estimated $824K sold.

Algert Global first reported a position in VCYT in Q2 2017 and held it in 23 quarters. The position peaked at $10.4M in Q4 2024. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.

  • Algert Global reported no remaining Veracyte position as of Q1 2026 after selling out during the quarter.
  • Algert Global sold 19,580 Veracyte shares in Q1 2026, an estimated $824K.
  • Algert Global first reported a position in Veracyte in Q2 2017 and held it in 23 quarters.
  • Algert Global's Veracyte position peaked at $10.4M in Q4 2024.
  • 334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.

Based on Algert Global's 13F filing for Q1 2026, filed 14 May 2026.